| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in TARS over the last quarter tilts toward selling: insiders offloaded a net 62,595 shares worth roughly $5.2M.
TARS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 828.0K | $75.57M | - | |
| Dir | 95.3K | $7.47M | - | |
| COO | 78.5K | $6.68M | - | |
| Other | 64.0K | $4.29M | - | |
| Other | 61.5K | $4.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2023 | Greenstein Leonard M. | Chief Financial Officer | Sell | 5,000 | $14.56 | $72,800.00 | -11.3% | -3.8% | +63.1% | |
| Jan 11, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 3,904 | $15.11 | $58,989.44 | -0.3% | -15.1% | +51.8% | |
| Jan 10, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 1,634 | $15.16 | $24,773.20 | -0.1% | -19.6% | +37.8% | |
| Jan 6, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 411 | $15.00 | $6,165.00 | - | -16.0% | +31.1% | |
| Dec 21, 2022 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $14.57 | $116,560.00 | -0.7% | -10.5% | +39.4% | |
| Dec 16, 2022 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 535 | $15.01 | $8,030.35 | - | -10.1% | +27.6% | |
| Dec 15, 2022 | Greenstein Leonard M. | Chief Financial Officer | Sell | 5,000 | $14.64 | $73,200.00 | -10.1% | -7.0% | +29.0% | |
| Dec 14, 2022 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 6,420 | $15.08 | $96,813.60 | -0.6% | -4.5% | +27.6% | |
| Dec 2, 2022 | Whitfield Dianne C. | Chief Human Resources Officer | Sell | 1,154 | $16.90 | $19,502.60 | -11.7% | -10.5% | -8.8% | |
| Dec 2, 2022 | Wahl Bryan | General Counsel | Sell | 1,154 | $16.90 | $19,502.60 | -7.8% | -10.5% | -8.8% |